Pharmaceuticals, Biotechnology and Life Sciences
SOMERVILLE, Mass., Aug. 25, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage…
SAN DIEGO, Aug. 25, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company and its…
Significant Milestones AchievedWINNIPEG, Manitoba, Aug. 25, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane…
Dr. Heron brings decades of experience in executive leadership and life sciences research and development to Vaxart’s BoardSOUTH SAN FRANCISCO,…
SALT LAKE CITY, Aug. 25, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and…
WALTHAM, Mass., Aug. 25, 2022 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new treatments for…
NEWS RELEASE – REGULATED INFORMATION25 AUGUST 2022, 4:00PM EDT, 22:00 CET MDxHealth Reports Half Year 2022 Results IRVINE, CA, and…
ORLANDO, FL, Aug. 25, 2022 (GLOBE NEWSWIRE) — Immune Therapeutics, Inc. (OTC PINK:IMUN) (“Immune” or “IMUN”), a pioneering pharmaceutical company…
BOCA RATON, Fla., Aug. 25, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”),…
Includes Full Exercise of Initial Purchaser’s Option to Purchase $10 Million of Additional NotesLAKE FOREST, Ill., Aug. 25, 2022 (GLOBE…